Predictions
Atossa Genetics Inc
Start price
Target price
Perf. (%)
€3.50
26.07.21
26.07.21
-
26.07.22
26.07.22
-74.03%
27.07.22
27.07.22
Probably not worthwhile Investment
Ardelyx Inc.
Start price
Target price
Perf. (%)
€1.32
26.07.21
26.07.21
-
26.07.22
26.07.22
-48.82%
27.07.22
27.07.22
Risky Investment
Dynatronics Corp
Start price
Target price
Perf. (%)
€1.07
26.07.21
26.07.21
€2.50
26.07.22
26.07.22
-1.87%
07.08.21
07.08.21
Could be worthwhile Investment >10% per year
Capable Management
Good culture
Few uniques
Trinity Biotech ADR
Start price
Target price
Perf. (%)
€1.66
26.07.21
26.07.21
-
26.07.22
26.07.22
-21.08%
27.07.22
27.07.22
Could be very worthwhile Investment >20% year
Sartorius AG ST
Start price
Target price
Perf. (%)
€480.00
25.07.21
25.07.21
€550.00
25.07.22
25.07.22
-18.33%
25.07.22
25.07.22
Valneva SE
Start price
Target price
Perf. (%)
€11.24
20.07.21
20.07.21
€20.00
20.07.22
20.07.22
116.90%
25.11.21
25.11.21
Could be worthwhile Investment >10% per year
Very valuable balance sheet
Stratec SE
Start price
Target price
Perf. (%)
€121.80
20.07.21
20.07.21
€135.00
20.07.22
20.07.22
4.76%
30.07.21
30.07.21
Risky Investment
Paul Hartmann AG
Start price
Target price
Perf. (%)
€360.00
14.07.21
14.07.21
€450.00
14.07.22
14.07.22
0.28%
24.07.21
24.07.21
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Fair valuation
Standard Investments for future growth
Seelos Therapeutics Inc.
Start price
Target price
Perf. (%)
€2.02
14.07.21
14.07.21
-
14.07.22
14.07.22
-24.07%
05.12.21
05.12.21
Allied Healthcare Products Inc
Start price
Target price
Perf. (%)
€5.75
14.07.21
14.07.21
-
14.07.22
14.07.22
-68.30%
15.07.22
15.07.22
Could be worthwhile Investment >10% per year
Chemocentryx Inc.
Start price
Target price
Perf. (%)
€14.10
13.07.21
13.07.21
€21.00
13.07.22
13.07.22
-10.78%
13.08.21
13.08.21
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Perrigo Co. plc
Start price
Target price
Perf. (%)
€39.00
13.07.21
13.07.21
-
13.07.22
13.07.22
-18.36%
02.05.22
02.05.22
Could be worthwhile Investment >10% per year
Undervalued
Higher risks for its business
Ryman Healthcare Group Ltd.
Start price
Target price
Perf. (%)
€7.98
13.07.21
13.07.21
€10.00
13.07.22
13.07.22
-31.03%
13.07.22
13.07.22
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Fair valuation
Capable Management
Chemocentryx Inc.
Start price
Target price
Perf. (%)
€13.66
13.07.21
13.07.21
-
13.07.22
13.07.22
69.13%
14.07.22
14.07.22
Could be worthwhile Investment >10% per year
Standard Investments for future growth
Sustainability is important
High valuation
Biolife Solutions Inc
Start price
Target price
Perf. (%)
€40.84
13.07.21
13.07.21
-
13.07.22
13.07.22
-62.81%
13.07.22
13.07.22
Medtronic plc
Start price
Target price
Perf. (%)
€108.20
12.07.21
12.07.21
-
12.07.24
12.07.24
-28.34%
11.03.24
11.03.24
Could be worthwhile Investment >10% per year
Catalyst Pharmaceutical Partners Inc
Start price
Target price
Perf. (%)
€4.66
12.07.21
12.07.21
-
12.07.22
12.07.22
48.95%
13.03.22
13.03.22
Alpha Pro Tech Ltd.
Start price
Target price
Perf. (%)
€6.22
11.07.21
11.07.21
€12.00
11.07.22
11.07.22
-30.03%
12.07.22
12.07.22
Could be worthwhile Investment >10% per year
Differentiated customer and product portfolio
Small cyclical dependencies
Undervalued
Inovio Pharma
Start price
Target price
Perf. (%)
€6.92
10.07.21
10.07.21
€5.80
10.07.22
10.07.22
-6.86%
27.11.21
27.11.21
Very low/no dividend yield expected
Risky balance sheet
ROE lower than 10% per year
Increased challenges to pay loans and raise capital